CTCL

Oncology·MeSH: Lymphoma, T-Cell, Cutaneous

8 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Approved(5)

Drug	Company
bexarotene	Amneal Pharmaceuticals, Inc. (AMRX)
istodax	BRISTOL MYERS SQUIBB CO (BMY)
LYMPHIR	Citius Pharmaceuticals, Inc. (CTXR)
LYMPHIR	CITIUS ONCOLOGY, INC. (CTOR)
LYMPHIR (denileukin diftitox-cdxl)	CITIUS ONCOLOGY, INC. (CTOR)

Phase 2(1)

Drug	Company
hypericin	SOLIGENIX, INC. (SNGX)

Phase 1(2)

Drug	Company
exoil-12	Codiak BioSciences, Inc. (CDAK)
tti-621	Trillium Therapeutics Inc. (TRIL)

BioSniper tracks 8 drugs in development for CTCL across 7 companies.

There are 1 clinical trial targeting CTCL tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.